- Research works
- 2 ▼ 100% vs 2013–17
- Citations
- 1 0.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Irbis (Czechia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Irbis (Czechia) publish most on?
By volume in 2022–2025: Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies and Metabolism and Genetic Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Epilepsy research and treatment Psychiatry and Mental health 0 works
- 2 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 0 works
- 3 Metabolism and Genetic Disorders Clinical Biochemistry 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
Other research institutions in Zlín
- Tomas Bata University in Zlín
- Av Engineering (Czechia)
- Krajská nemocnice T. Bati
- Nemocnice Atlas
- Gemini Eye Clinic
- Institute for Testing and Certification (Czechia)
- Strojírenské Inovační Centrum (Czechia)
- Compuplast International (Czechia)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.